Praxis Precision Medicines, Inc. PRAX Business Segments — Depreciation expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s business segments — depreciation expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s business segments — depreciation expense?
- Praxis Precision Medicines, Inc. (PRAX) reported business segments — depreciation expense of $39K in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s business segments — depreciation expense changed year-over-year?
- Praxis Precision Medicines, Inc.'s business segments — depreciation expense decreased by 17.0% year-over-year, from $47K to $39K.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s business segments — depreciation expense?
- Over 2 years (2023 to 2025), Praxis Precision Medicines, Inc.'s business segments — depreciation expense has grown at a -43.1% compound annual growth rate (CAGR), from $432K to $140K.
- What does business segments — depreciation expense mean?
- This metric represents the systematic allocation of the cost of tangible assets over their useful lives within the business segment. It reflects the wear and tear or obsolescence of laboratory equipment and infrastructure used in clinical research. It is a non-cash expense that impacts the segment's reported operating results.